Sign in

CIK 0000921114

  • Non-accelerated filer
  • Smaller reporting company

Armata Pharmaceuticals, Inc.

Sign in to watch
Ticker
ARMP
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
911549568
Phone
+1 310-665-2928
Business address
5005 MCCONNELL AVE, LOS ANGELES, CA, 90066
Former names
AmpliPhi Biosciences Corp, TARGETED GENETICS CORP /WA/
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale 10% owner sold 14,200 shares at an average $0.71 ($10,043)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale 10% owner sold 25,000 shares at an average $0.73 ($18,263)
  8. 4 Open-market sale 10% owner sold 25,453 shares at an average $0.76 ($19,325)
  9. 4 Open-market sale 10% owner sold 37,500 shares at an average $0.76 ($28,675)
  10. 4 Open-market sale 10% owner sold 26,200 shares at an average $0.77 ($20,211)
  11. 4 Open-market sale 10% owner sold 33,000 shares at an average $0.78 ($25,791)
  12. 4 Open-market sale 10% owner sold 36,500 shares at an average $0.81 ($29,481)
  13. 4/A Open-market sale 10% owner sold 73,500 shares at an average $0.84 ($61,584)
  14. 4/A Open-market sale 10% owner sold 35,098 shares at an average $0.79 ($27,791)
  15. 4/A Open-market sale 10% owner sold 17,000 shares at an average $0.81 ($13,726)
  16. 4/A Open-market sale 10% owner sold 74,632 shares at an average $0.80 ($59,671)
  17. 4 Open-market sale 10% owner sold 73,500 shares at an average $0.84 ($61,584)
  18. 4 Open-market sale 10% owner sold 35,098 shares at an average $0.79 ($27,791)
  19. 4 Open-market sale 10% owner sold 17,000 shares at an average $0.81 ($13,726)
  20. 4 Derivatives Options or other derivatives

Page 12 of 14 · 267 filings